Uniphar trading up after meeting expectations in 2024 [Video]

Shares in Uniphar plc have increased 5% in trade on Tuesday after the pharma services, wholesale and retail group announced it had performed in line with expectations last year.

In a full-year trading update, Uniphar said earnings per share had met expectations, and that it had delivered normalised free cashflow conversion above our medium-term guidance.

The group achieved over 8% growth in organic gross profit and 12% adjusted EPS growth while maintaining a strong liquidity position, with lower than projected net debt to EBITDA of 1.5x at year-end.

Looking ahead, Uniphar said it was well-positioned to deliver organic gross profit growth across all divisions.

The group expects to see organic gross profit growth in 2025 across its three divisions, with double-digit growth projected in its pharma business, high single-digit growth in its medtech business, and low single-digit growth in its supply chain and retail business.

Uniphar said that M&Awould continue to play an important role …